ClinicalTrials.gov record
Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.
ClinicalTrials.gov ID: NCT00471146
Public ClinicalTrials.gov record NCT00471146. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind Phase 3 Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine Plus Placebo For The First-Line Treatment Of Patients With Locally Advanced, Unresectable Or Metastatic Pancreatic Cancer.
Study identification
- NCT ID
- NCT00471146
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 630 participants
Conditions and interventions
Conditions
Interventions
- AG-013736 Drug
- Gemcitabine Drug
- placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2007
- Primary completion
- Dec 31, 2008
- Completion
- Oct 31, 2010
- Last update posted
- Jul 15, 2012
2007 – 2010
United States locations
- U.S. sites
- 77
- U.S. states
- 24
- U.S. cities
- 60
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Antioch | California | 94531 | — |
| Pfizer Investigational Site | Corona | California | 92878 | — |
| Pfizer Investigational Site | Glendora | California | 91741 | — |
| Pfizer Investigational Site | La Jolla | California | 92037 | — |
| Pfizer Investigational Site | La Jolla | California | 92093 | — |
| Pfizer Investigational Site | LaVerne | California | 91750 | — |
| Pfizer Investigational Site | Pasadena | California | 91105 | — |
| Pfizer Investigational Site | Pleasent Hill | California | 94523 | — |
| Pfizer Investigational Site | Pomona | California | 91105 | — |
| Pfizer Investigational Site | Pomona | California | 91767 | — |
| Pfizer Investigational Site | Rancho Cucamonga | California | 91730 | — |
| Pfizer Investigational Site | Rancho Mirage | California | 92270 | — |
| Pfizer Investigational Site | Redlands | California | 92374 | — |
| Pfizer Investigational Site | San Diego | California | 92103 | — |
| Pfizer Investigational Site | San Diego | California | 92161 | — |
| Pfizer Investigational Site | San Leandro | California | 94578 | — |
| Pfizer Investigational Site | West Covina | California | 91790 | — |
| Pfizer Investigational Site | Hollywood | Florida | 33021 | — |
| Pfizer Investigational Site | Pembroke Pines | Florida | 33028 | — |
| Pfizer Investigational Site | Stuart | Florida | 34994 | — |
| Pfizer Investigational Site | Tampa | Florida | 33612 | — |
| Pfizer Investigational Site | Atlanta | Georgia | 30309 | — |
| Pfizer Investigational Site | Augusta | Georgia | 30901 | — |
| Pfizer Investigational Site | Augusta | Georgia | 30909 | — |
| Pfizer Investigational Site | Coeur d'Alene | Idaho | 83814 | — |
| Pfizer Investigational Site | Alton | Illinois | 62002 | — |
| Pfizer Investigational Site | Chicago | Illinois | 60637 | — |
| Pfizer Investigational Site | Beech Grove | Indiana | 46107 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46237 | — |
| Pfizer Investigational Site | Indianapolis | Indiana | 46260 | — |
| Pfizer Investigational Site | Jeffersonville | Indiana | 47130 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40202 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40207 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40217 | — |
| Pfizer Investigational Site | Louisville | Kentucky | 40241 | — |
| Pfizer Investigational Site | Shelbyville | Kentucky | 40065 | — |
| Pfizer Investigational Site | Baton Rouge | Louisiana | 70806 | — |
| Pfizer Investigational Site | Baton Rouge | Louisiana | 70809 | — |
| Pfizer Investigational Site | Annapolis | Maryland | 21401 | — |
| Pfizer Investigational Site | Burlington | Massachusetts | 01805 | — |
| Pfizer Investigational Site | Peabody | Massachusetts | 01960 | — |
| Pfizer Investigational Site | Kalamazoo | Michigan | 49007 | — |
| Pfizer Investigational Site | Columbus | Mississippi | 39705 | — |
| Pfizer Investigational Site | Corinth | Mississippi | 38834 | — |
| Pfizer Investigational Site | Southaven | Mississippi | 38671 | — |
| Pfizer Investigational Site | Tupelo | Mississippi | 38801 | — |
| Pfizer Investigational Site | St Louis | Missouri | 63136 | — |
| Pfizer Investigational Site | Billings | Montana | 59101 | — |
| Pfizer Investigational Site | Lincoln | Nebraska | 68510 | — |
| Pfizer Investigational Site | Las Vegas | Nevada | 89135 | — |
| Pfizer Investigational Site | Mineola | New York | 11501 | — |
| Pfizer Investigational Site | Syracuse | New York | 13210 | — |
| Pfizer Investigational Site | Canton | Ohio | 44718 | — |
| Pfizer Investigational Site | Columbus | Ohio | 43214 | — |
| Pfizer Investigational Site | Sylvania | Ohio | 43560 | — |
| Pfizer Investigational Site | Portland | Oregon | 97227-1191 | — |
| Pfizer Investigational Site | Knoxville | Tennessee | 37916 | — |
| Pfizer Investigational Site | Knoxville | Tennessee | 37920 | — |
| Pfizer Investigational Site | Knoxville | Tennessee | 37934 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38104 | — |
| Pfizer Investigational Site | Memphis | Tennessee | 38120 | — |
| Pfizer Investigational Site | Austin | Texas | 78705 | — |
| Pfizer Investigational Site | Austin | Texas | 78745 | — |
| Pfizer Investigational Site | Austin | Texas | 78758 | — |
| Pfizer Investigational Site | Austin | Texas | 78759 | — |
| Pfizer Investigational Site | Dallas | Texas | 75325-7786 | — |
| Pfizer Investigational Site | Dallas | Texas | 75325 | — |
| Pfizer Investigational Site | Dallas | Texas | 75390 | — |
| Pfizer Investigational Site | Round Rock | Texas | 78664 | — |
| Pfizer Investigational Site | Salt Lake City | Utah | 84112 | — |
| Pfizer Investigational Site | Lynchburg | Virginia | 24501 | — |
| Pfizer Investigational Site | Everett | Washington | 98201 | — |
| Pfizer Investigational Site | Federal Way | Washington | 98003 | — |
| Pfizer Investigational Site | Kennewick | Washington | 99336 | — |
| Pfizer Investigational Site | Lakewood | Washington | 98499 | — |
| Pfizer Investigational Site | Puyallup | Washington | 98372 | — |
| Pfizer Investigational Site | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 127 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00471146, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 15, 2012 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00471146 live on ClinicalTrials.gov.